Rahman N. Realizing the promise of cancer predisposition genes. Nature. 2014;505(7483):302–8.

Article  CAS  Google Scholar 

Lynch HT, Snyder CL, Shaw TG, Heinen CD, Hitchins MP. Milestones of Lynch syndrome: 1895–2015. Nat Rev Cancer. 2015;15(3):181–94.

Article  CAS  Google Scholar 

Dukes CE. Familial intestinal polyposis. Ann Eugen. 1952;17(Part 1):1–29.

CAS  Google Scholar 

Plazzer JP, Sijmons RH, Woods MO, Peltomaki P, Thompson B, Den Dunnen JT, et al. The InSiGHT database: utilizing 100 years of insights into Lynch syndrome. Fam Cancer. 2013;12(2):175–80.

Article  CAS  Google Scholar 

Hino O, Kobayashi T. Mourning Dr. Alfred G. Knudson: the two-hit hypothesis, tumor suppressor genes, and the tuberous sclerosis complex. Cancer Sci. 2017;108(1):5–11.

Article  CAS  Google Scholar 

Berry JL, Polski A, Cavenee WK, Dryja TP, Murphree AL, Gallie BL. The RB1 Story: Characterization and Cloning of the First Tumor Suppressor Gene. Genes (Basel). 2019;10(11):879.

Article  CAS  Google Scholar 

Friedrich A, Kullmann F. Familial adenomatous polyposis syndrome (FAP): pathogenesis and molecular mechanisms. Med Klin (Munich). 2003;98(12):776–82.

Article  CAS  Google Scholar 

Botstein D, Risch N. Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease. Nat Genet. 2003;33(Suppl):228–37.

Article  CAS  Google Scholar 

Turnbull C, Sud A, Houlston RS. Cancer genetics, precision prevention and a call to action. Nat Genet. 2018;50(9):1212–8.

Article  CAS  Google Scholar 

Valle L. Genetic predisposition to colorectal cancer: where we stand and future perspectives. World J Gastroenterol. 2014;20(29):9828–49.

Article  CAS  Google Scholar 

Valle L, de Voer RM, Goldberg Y, Sjursen W, Forsti A, Ruiz-Ponte C, et al. Update on genetic predisposition to colorectal cancer and polyposis. Mol Aspects Med. 2019;69:10–26.

Article  CAS  Google Scholar 

MacArthur J, Bowler E, Cerezo M, Gil L, Hall P, Hastings E, et al. The new NHGRI-EBI Catalog of published genome-wide association studies (GWAS Catalog). Nucleic Acids Res. 2017;45(D1):D896–901.

Article  CAS  Google Scholar 

Tam V, Patel N, Turcotte M, Bosse Y, Pare G, Meyre D. Benefits and limitations of genome-wide association studies. Nat Rev Genet. 2019;20(8):467–84.

Article  CAS  Google Scholar 

Loos RJF. 15 years of genome-wide association studies and no signs of slowing down. Nat Commun. 2020;11(1):5900.

Article  CAS  Google Scholar 

Huyghe JR, Bien SA, Harrison TA, Kang HM, Chen S, Schmit SL, et al. Discovery of common and rare genetic risk variants for colorectal cancer. Nat Genet. 2019;51(1):76–87.

Article  CAS  Google Scholar 

Ott J, Wang J, Leal SM. Genetic linkage analysis in the age of whole-genome sequencing. Nat Rev Genet. 2015;16(5):275–84.

Article  CAS  Google Scholar 

Gibson G. Rare and common variants: twenty arguments. Nat Rev Genet. 2012;13(2):135–45.

Article  CAS  Google Scholar 

OMIM. Available from: https://www.omim.org/.

Hemminki K, Sundquist K, Sundquist J, Forsti A, Hemminki A, Li X. Familial Risks and Proportions Describing Population Landscape of Familial Cancer. Cancers (Basel). 2021;13(17):4385.

Article  CAS  Google Scholar 

Luchini C, Bibeau F, Ligtenberg MJL, Singh N, Nottegar A, Bosse T, et al. ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approach. Ann Oncol. 2019;30(8):1232–43.

Article  CAS  Google Scholar 

Moller P, Seppala TT, Bernstein I, Holinski-Feder E, Sala P, Gareth Evans D, et al. Cancer risk and survival in path_MMR carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database. Gut. 2018;67(7):1306–16.

Article  Google Scholar 

NIH. Polygenic Trait: NIH; Available from: https://www.genome.gov/genetics-glossary/Polygenic-Trait.

Lewis CM, Vassos E. Polygenic risk scores: from research tools to clinical instruments. Genome Med. 2020;12(1):44.

Article  Google Scholar 

Frampton MJ, Law P, Litchfield K, Morris EJ, Kerr D, Turnbull C, et al. Implications of polygenic risk for personalised colorectal cancer screening. Ann Oncol. 2016;27(3):429–34.

Article  CAS  Google Scholar 

Kullo IJ, Lewis CM, Inouye M, Martin AR, Ripatti S, Chatterjee N. Polygenic scores in biomedical research. Nat Rev Genet. 2022;23(9):524–32.

Article  CAS  Google Scholar 

Varghese JS, Easton DF. Genome-wide association studies in common cancers–what have we learnt? Curr Opin Genet Dev. 2010;20(3):201–9.

Article  CAS  Google Scholar 

Hirschhorn JN. Genomewide association studies–illuminating biologic pathways. N Engl J Med. 2009;360(17):1699–701.

Article  CAS  Google Scholar 

Low SK, Takahashi A, Mushiroda T, Kubo M. Genome-wide association study: a useful tool to identify common genetic variants associated with drug toxicity and efficacy in cancer pharmacogenomics. Clin Cancer Res. 2014;20(10):2541–52.

Article  CAS  Google Scholar 

Vieland VJ, Devoto M. Next-generation linkage analysis. Hum Hered. 2011;72(4):227.

Article  Google Scholar 

Palles C, Cazier JB, Howarth KM, Domingo E, Jones AM, Broderick P, et al. Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas. Nat Genet. 2013;45(2):136–44.

Article  CAS  Google Scholar 

Weren RD, Ligtenberg MJ, Geurts van Kessel A, De Voer RM, Hoogerbrugge N, Kuiper RP. NTHL1 and MUTYH polyposis syndromes: two sides of the same coin? J Pathol. 2018;244(2):135–42.

Article  Google Scholar 

Adam R, Spier I, Zhao B, Kloth M, Marquez J, Hinrichsen I, et al. Exome Sequencing Identifies Biallelic MSH3 Germline Mutations as a Recessive Subtype of Colorectal Adenomatous Polyposis. Am J Hum Genet. 2016;99(2):337–51.

Article  CAS  Google Scholar 

Olkinuora A, Nieminen TT, Martensson E, Rohlin A, Ristimaki A, Koskenvuo L, et al. Biallelic germline nonsense variant of MLH3 underlies polyposis predisposition. Genet Med. 2019;21(8):1868–73.

Article  CAS  Google Scholar 

Jaeger E, Leedham S, Lewis A, Segditsas S, Becker M, Cuadrado PR, et al. Hereditary mixed polyposis syndrome is caused by a 40-kb upstream duplication that leads to increased and ectopic expression of the BMP antagonist GREM1. Nat Genet. 2012;44(6):699–703.

Article  CAS  Google Scholar 

Carballal S, Rodriguez-Alcalde D, Moreira L, Hernandez L, Rodriguez L, Rodriguez-Moranta F, et al. Colorectal cancer risk factors in patients with serrated polyposis syndrome: a large multicentre study. Gut. 2016;65(11):1829–37.

Article  Google Scholar 

Valle L. Recent Discoveries in the Genetics of Familial Colorectal Cancer and Polyposis. Clin Gastroenterol Hepatol. 2017;15(6):809–19.

Article  CAS  Google Scholar 

Levkova M, Stoyanova M, Benkova-Petrova M, Georgieva M, Angelova L. Variants of uncertain significance in the era of next-generation sequencing. J Am Assoc Nurse Pract. 2022;34(8):1018–21.

Article  Google Scholar 

Lucci-Cordisco E, Amenta S, Panfili A, Del Valle J, Capella G, Pineda M, et al. Variants of uncertain significance (VUS) in cancer predisposing genes: What are we learning from multigene panels? Eur J Med Genet. 2022;65(1):104400.

Article  CAS  Google Scholar 

Miller DT, Lee K, Chung WK, Gordon AS, Herman GE, Klein TE, et al. ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2021;23(8):1381–90.

Article  Google Scholar 

NCBI. ClinVar Miner. Available from: https://clinvarminer.genetics.utah.edu/.

Esteban-Jurado C, Franch-Exposito S, Munoz J, Ocana T, Carballal S, Lopez-Ceron M, et al. The Fanconi anemia DNA damage repair pathway in the spotlight for germline predisposition to colorectal cancer. Eur J Hum Genet. 2016;24(10):1501–5.

Article  CAS  Google Scholar 

Garre P, Martin L, Sanz J, Romero A, Tosar A, Bando I, et al. BRCA2 gene: a candidate for clinical testing in familial colorectal cancer type X. Clin Genet. 2015;87(6):582–7.

Article  CAS  Google Scholar 

Kumar A, Bandapalli OR, Paramasivam N, Giangiobbe S, Diquigiovanni C, Bonora E, et al. Familial Cancer Variant Prioritization Pipeline version 2 (FCVPPv2) applied to a papillary thyroid cancer family. Sci Rep. 2018;8(1):11635.

Article  Google Scholar